Mária Lódi

659 total citations
9 papers, 119 citations indexed

About

Mária Lódi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mária Lódi has authored 9 papers receiving a total of 119 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 2 papers in Molecular Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mária Lódi's work include Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Cardiomyopathy and Myosin Studies (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Mária Lódi is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (4 papers), Cardiomyopathy and Myosin Studies (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Mária Lódi collaborates with scholars based in Hungary, Germany and Australia. Mária Lódi's co-authors include Zoltán Papp, Árṕad Kov́acs, Nazha Hamdani, Andreas Mügge, Melissa Herwig, Detmar Kolijn, Kornélia Jaquet, Peter Haldenwang, Wolfgang A. Linke and Sophie Van Linthout and has published in prestigious journals such as The Journal of Physiology, Frontiers in Physiology and Neuro-Oncology.

In The Last Decade

Mária Lódi

8 papers receiving 119 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mária Lódi Hungary 5 101 40 13 12 10 9 119
Friedrich-Wilhelm Mohr Germany 5 74 0.7× 59 1.5× 5 0.4× 8 0.7× 9 0.9× 7 132
Jei-Keon Chae South Korea 5 107 1.1× 40 1.0× 12 0.9× 2 0.2× 5 0.5× 11 167
Dao Wu Wang China 6 102 1.0× 77 1.9× 11 0.8× 4 0.3× 4 0.4× 11 150
Vincent Duval France 4 55 0.5× 49 1.2× 4 0.3× 9 0.8× 5 0.5× 4 102
Sebastian Korste Germany 6 61 0.6× 33 0.8× 14 1.1× 14 1.2× 5 0.5× 11 135
D. H. Kim South Korea 3 31 0.3× 51 1.3× 13 1.0× 4 0.3× 9 0.9× 3 93
Jeremy Nicolarsen United States 7 59 0.6× 38 0.9× 57 4.4× 4 0.3× 13 1.3× 10 132
Matthew D. Campbell United States 7 27 0.3× 76 1.9× 5 0.4× 7 0.6× 32 3.2× 16 138
Joanna Helmy United Kingdom 5 34 0.3× 52 1.3× 6 0.5× 6 0.5× 3 0.3× 8 139
Jennifer Arroyo United States 6 21 0.2× 75 1.9× 11 0.8× 26 2.2× 12 1.2× 9 129

Countries citing papers authored by Mária Lódi

Since Specialization
Citations

This map shows the geographic impact of Mária Lódi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mária Lódi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mária Lódi more than expected).

Fields of papers citing papers by Mária Lódi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mária Lódi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mária Lódi. The network helps show where Mária Lódi may publish in the future.

Co-authorship network of co-authors of Mária Lódi

This figure shows the co-authorship network connecting the top 25 collaborators of Mária Lódi. A scholar is included among the top collaborators of Mária Lódi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mária Lódi. Mária Lódi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lódi, Mária, Árṕad Kov́acs, Nazha Hamdani, et al.. (2020). Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy. Journal of Translational Medicine. 18(1). 470–470. 10 indexed citations
2.
Kolijn, Detmar, Árṕad Kov́acs, Melissa Herwig, et al.. (2020). Enhanced Cardiomyocyte Function in Hypertensive Rats With Diastolic Dysfunction and Human Heart Failure Patients After Acute Treatment With Soluble Guanylyl Cyclase (sGC) Activator. Frontiers in Physiology. 11. 345–345. 36 indexed citations
3.
Herwig, Melissa, Detmar Kolijn, Mária Lódi, et al.. (2020). Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D. Frontiers in Physiology. 11. 240–240. 31 indexed citations
4.
Hamdani, Nazha, Detmar Kolijn, Mária Lódi, et al.. (2020). Endothelial and Cardiomyocyte Dysfunction in Heart Failure with Preserved Ejection Fraction Is Attenuated via PDE9A Inhibition. The Thoracic and Cardiovascular Surgeon. 2 indexed citations
5.
Reil, Jan‐Christian, Gert‐Hinrich Reil, Árṕad Kov́acs, et al.. (2020). CaMKII activity contributes to homeometric autoregulation of the heart: A novel mechanism for the Anrep effect. The Journal of Physiology. 598(15). 3129–3153. 21 indexed citations
6.
Cacchione, Antonella, Evelina Miele, Mária Lódi, et al.. (2020). LGG-18. EVEROLIMUS TREATMENT IN PEDIATRIC PATIENTS AFFECTED BY LOW-GRADE GLIOMAS (pLGG) NON-TSC, BRAF v600-WT. Neuro-Oncology. 22(Supplement_3). iii369–iii369. 2 indexed citations
7.
Lódi, Mária, Dániel Priksz, Gábor Áron Fülöp, et al.. (2019). Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy. Journal of Translational Medicine. 17(1). 229–229. 16 indexed citations
8.
Lódi, Mária, Dániel Czuriga, István Czuriga, et al.. (2017). Ischaemiás szívbetegség és tumoros betegségek együttes előfordulása. Kérdések és problémák. Orvosi Hetilap. 158(43). 1691–1697.
9.
Lódi, Mária, et al.. (2017). [New recommendations in oncocardiology].. PubMed. 61(3). 219–227. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026